| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| R682047 | 2488648-40-2 | (R)-6-(2-(5-氟-2-羟基吡啶-3-基)吡咯烷-1-基)咪唑并[1,2-b]哒嗪-3-羧酸乙酯, 95% ethyl (R)-6-(2-(5-fluoro-2-hydroxypyridin-3-yl)pyrrolidin-1-yl)imidazo[1,2-b]pyridazine-3-carboxylate, 95% |
C18H18FN5O3 | |
| R984791 | 2090270-33-8 | (R)-6-甲基-4,5,6,7-四氢吡唑并[1,5-a]吡嗪, ≥97% (R)-6-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine, ≥97% |
C7H11N3 | |
| R840127 | 1022093-98-6 | (R)-N-Boc-3-甲基吗啡啉, 97% (R)-N-Boc-3-Methylmorpholine, 97% |
C10H19NO3 | |
| R685783 | 1126432-04-9 | (R)-八氢吡嗪并[2,1-c][1,4]恶嗪二盐酸盐, 99% (R)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride, 99% |
C7H16Cl2N2O | |
| R942058 | 481038-74-8 | (R)-叔-丁基 2,4-二苯甲基哌嗪-1-甲酸基酯, 95% (R)-tert-Butyl 2,4-dibenzylpiperazine-1-carboxylate, 95% |
C23H30N2O2 | |
| R900796 | 143577-46-2 | (R)-四氢-3H-吡咯并[1,2-c] [1,2,3]恶噻唑1,1-二氧化物, ≥95% (R)-Tetrahydro-3H-pyrrolo[1,2-c][1,2,3]oxathiazole 1,1-dioxide, ≥95% |
C5H9NO3S | |
| S681886 | 2890725-97-8 | (S) -3-(3-(6-氨基己烷-2-基)-4-氯-3H-咪唑并[4,5-c]吡啶-2-基)氨甲酰基)苯甲酸, 95% (S)-3-((3-(6-aminohexan-2-yl)-4-chloro-3H-imidazo[4,5-c]pyridin-2-yl)carbamoyl)benzoic acid, 95% |
C20H22ClN5O3 | |
| S682111 | 2664901-52-2 | (S) -3-(7-氯-6-((四氢呋喃-3-基)氧基)咪唑并[1,2-b]哒嗪-3-基)-4,5-二氟-N-甲基苯甲酰胺, 95% (S)-3-(7-chloro-6-((tetrahydrofuran-3-yl)oxy)imidazo[1,2-b]pyridazin-3-yl)-4,5-difluoro-N-methylbenzamide, 95% |
C18H15ClF2N4O3 | |
| S682112 | 2664901-70-4 | (S) -3-(7-氯-6-((四氢呋喃-3-基)氧基)咪唑并[1,2-b]哒嗪-3-基)-5-(二氟甲基)-4-氟-N-甲基苯甲酰胺, 95% (S)-3-(7-chloro-6-((tetrahydrofuran-3-yl)oxy)imidazo[1,2-b]pyridazin-3-yl)-5-(difluoromethyl)-4-fluoro-N-methylbenzamide, 95% |
C19H16ClF3N4O3 | |
| S682110 | 2664901-51-1 | (S) -3-溴-7-氯-6-((四氢呋喃-3-基)氧基)咪唑并[1,2-b]哒嗪, 95% (S)-3-bromo-7-chloro-6-((tetrahydrofuran-3-yl)oxy)imidazo[1,2-b]pyridazine, 95% |
C10H9BrClN3O2 | |
| S682107 | 2838090-04-1 | (S) -6-(3-(((2-甲基-[1,1'-联苯]-3-基)甲氧基)羰基)氨基)吡咯烷-1-基)咪唑并[1,2-b]哒嗪-2-羧酸, 95% (S)-6-(3-((((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)carbonyl)amino) pyrrolidin-1-yl)imidazo[1,2-b]pyridazine-2-carboxylic acid, 95% |
C26H25N5O4 | |
| S681845 | 3024681-56-6 | (S) -6-(4,4-二氟吡咯烷-3-基)氧基)-1-(2,2,2-三氟乙基)-1H-吡唑并[4,3-c]吡啶盐酸盐, 95% (S)-6-((4,4-difluoropyrrolidin-3-yl)oxy)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[4,3-c]pyridine hydrochloride, 95% |
C12H12F5ClN4O | |
| S682118 | 1470071-75-0 | (S) -8-(3-甲基吗啉-4-基)-6-氯咪唑并[1,2-b]哒嗪, 95% (S)-8-(3-methyl morpholin-4-yl)-6-chloro-imidazo[1,2-b]pyridazine, 95% |
C11H13ClN4O | |
| S682023 | 2937543-57-0 | (S)-(1-(3-((5-氨基-3-((3-氯-5-(三氟甲基)苯基)氨甲酰基)-2-甲基苯基)乙炔基)咪唑并[1,2-b]哒嗪-6-基)哌啶-3-基)氨基甲酸酯, 95% tert-butyl (S)-(1-(3-((5-amino-3-((3-chloro-5-(trifluoromethyl)phenyl)carbamoyl)-2-methylphenyl)ethynyl)imidazo[1,2-b]pyridazin-6-yl)piperidin-3-yl)carbamate, 95% |
C33H33ClF3N7O3 | |
| S682022 | 2937543-55-8 | (S)-(1-(3-碘代咪唑并[1,2-b]哒嗪-6-基)哌啶-3-基)氨基甲酸叔丁酯, 95% tert-butyl (S)-(1-(3-iodoimidazo[1,2-b]pyridazin-6-yl)piperidin-3-yl)carbamate, 95% |
C16H22IN5O2 | |
| S737409 | 1306763-71-2 | (S)-(4-(5-(3-氰基-4-异丙氧基苯基)-1,2,4-恶二唑-3-基)-2,3-二氢-1H-茚-1-基)氨基甲酸叔丁酯, 97% (S)-tert-Butyl (4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)carbamate, 97% |
C26H28N4O4 | |
| P765031 | 2197504-56-4 | (S)-1-(叔丁氧基羰基)-3,3-二氟哌啶-4-羧酸, 97% 1,4-Piperidinedicarboxylic acid, 3,3-difluoro-, 1-(1,1-dimethylethyl) ester, (4S)-, 97% |
C11H17F2NO4 | |
| S737319 | 200184-60-7 | (S)-1-苄基 2-甲基 4-亚甲基吡咯烷-1,2-二羧酸酯, 97% (S)-1-Benzyl 2-methyl 4-methylenepyrrolidine-1,2-dicarboxylate, 97% |
C15H17NO4 | |
| S682097 | 3059765-25-9 | (S)-2-(((苄氧基)羰基)氨基)(4,4-二氟环己基)甲基)-7-氯咪唑并[1,2-b]哒嗪-6-羧酸甲酯, 95% methyl (S)-2-((((benzyloxy)carbonyl)amino)(4,4-difluorocyclohexyl)methyl)-7-chloroimidazo[1,2-b]pyridazine-6-carboxylate, 95% |
C23H23ClF2N4O4 | |
| S927752 | 79839-26-2 | (S)-2-(3-((叔丁氧基羰基)氨基)-2-氧代吡咯烷-1-基)乙酸, 97% (S)-2-(3-((tert-Butoxycarbonyl)amino)-2-oxopyrrolidin-1-yl)acetic acid, 97% |
C11H18N2O5 |